MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Thermo Fisher Scientific Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

482.34 -3.02

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

480.83

Max

497.32

Pagrindiniai rodikliai

By Trading Economics

Pajamos

194M

1.8B

Pardavimai

795M

11B

P/E

Sektoriaus vid.

30.121

73.239

Pelnas, tenkantis vienai akcijai

6.1

Dividendų pajamingumas

0.35

Pelno marža

16.007

Darbuotojai

125,000

EBITDA

377M

3B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+33.04% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.35%

3.06%

Kitas uždarbis

2025-04-23

Kitas dividendų mokėjimo data

2025-04-15

Kita Ex Dividend data

2025-06-13

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-40B

189B

Ankstesnė atidarymo kaina

485.36

Ankstesnė uždarymo kaina

482.34

Naujienos nuotaikos

By Acuity

29%

71%

78 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Thermo Fisher Scientific Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-25 14:05; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

2025-01-30 11:43; UTC

Uždarbis

Thermo Fisher Scientific Profit, Revenue Rose in 4Q

2024-10-23 10:43; UTC

Uždarbis

Thermo Fisher Raises Floor of Earnings Target After Steady 3Q Sales

2025-02-25 14:09; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

2025-02-25 13:41; UTC

Įsigijimai, susijungimai, perėmimai

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

2025-02-25 13:40; UTC

Įsigijimai, susijungimai, perėmimai

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

2025-02-25 13:40; UTC

Įsigijimai, susijungimai, perėmimai

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

2025-02-25 13:40; UTC

Įsigijimai, susijungimai, perėmimai

Solventum Expects Deal to Be Neutral to 2025 EPS >SOLV

2025-02-25 13:40; UTC

Įsigijimai, susijungimai, perėmimai

Solventum: Deal Accelerates Business Transformation and Sharpens Focus on Strategic Areas for Growth

2025-02-25 13:39; UTC

Įsigijimai, susijungimai, perėmimai

Solventum Announces Sale of Its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

2025-02-25 13:33; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher: Solventum Business Generated About $1 Billion Revenue in 2024 >TMO

2025-02-25 13:32; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher to Buy Solventum Purification, Filtration Business for About $4.1 Billion Cash >TMO SOLV

2025-02-25 13:32; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher Scientific To Acquire Solventum's Purification And Filtration Business >TMO

2025-02-24 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Thermo Fisher Scientific Nears Deal for Solventum's Purification and Filtration Business, Sources Say -- WSJ

2025-02-24 23:03; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

Thermo Fisher Nears Deal for Solventum Filtration Unit -- WSJ

2025-02-24 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Deal Could be Announced This Week, Sources Say -- WSJ

2025-02-24 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Transaction Could Value Solventum Filtration Business Between $3.5B to $4B, Sources Say -- WSJ

2025-01-30 11:06; UTC

Uždarbis

Thermo Fisher: In a Great Position to Deliver Excellent Performance in 2025 >TMO

2025-01-30 11:05; UTC

Uždarbis

Thermo Fisher: Will Provide 2025 Fincl Guidance During Earnings Conference Call Thursday Morning >TMO

2025-01-30 11:00; UTC

Uždarbis

Thermo Fisher 4Q Rev $11.4B >TMO

2025-01-30 11:00; UTC

Uždarbis

Thermo Fisher 4Q EPS $4.78 >TMO

2025-01-30 11:00; UTC

Uždarbis

Thermo Fisher 4Q Core Organic Revenue Up 5% >TMO

2025-01-30 11:00; UTC

Uždarbis

Thermo Fisher 4Q Net $1.83B >TMO

2025-01-30 11:00; UTC

Uždarbis

Thermo Fisher 4Q Adj EPS $6.10 >TMO

2024-12-16 22:03; UTC

Svarbiausios naujienos

Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com

2024-10-23 10:02; UTC

Uždarbis

Thermo Fisher Had Seen 2024 Adjusted EPS $21.29-$22.07 >TMO

2024-10-23 10:02; UTC

Uždarbis

Thermo Fisher Backs 2024 View of Rev $42.4B-$43.3B >TMO

2024-10-23 10:00; UTC

Uždarbis

Thermo Fisher 3Q Core Organic Revenue 0% >TMO

2024-10-23 10:00; UTC

Uždarbis

Thermo Fisher 3Q EPS $4.25 >TMO

2024-10-23 10:00; UTC

Uždarbis

Thermo Fisher 3Q Adj EPS $5.28 >TMO

Akcijų palyginimas

Kainos pokytis

Thermo Fisher Scientific Inc Prognozė

Kainos tikslas

By TipRanks

33.04% į viršų

12 mėnesių prognozė

Vidutinis 662 USD  33.04%

Aukščiausias 715 USD

Žemiausias 570 USD

Remiantis 18 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Thermo Fisher Scientific Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

18 ratings

15

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

N/A / 519.57Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

78 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar